Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ACMG/AMP variant classification specifications from the ClinGen Epilepsy Sodium Channel Variant Curation Expert Panel.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes?

NPJ genomic medicine·2026
Same author

Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies.

JAMA neurology·2026
Same author

DNM1-related disorder is characterized by recurrent variants and phenotypic homogeneity.

medRxiv : the preprint server for health sciences·2026
Same author

A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsy.

Molecular genetics and metabolism·2026
Same author

Disrupted O-GalNAc glycosylation as a mechanism and biomarker of <i>SLC35A2</i>-associated epilepsy.

bioRxiv : the preprint server for biology·2026
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

The epilepsy phenome/genome project.

, Bassel Abou-Khalil, Brian Alldredge

    Clinical Trials (London, England)
    |July 3, 2013
    PubMed
    Summary
    This summary is machine-generated.

    The Epilepsy Phenome/Genome Project (EPGP) is a large study investigating genetic factors in epilepsy. It highlights effective management and data strategies for complex genetic research in neurological disorders.

    More Related Videos

    Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy
    04:41

    Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy

    Published on: October 13, 2023

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
    08:26

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

    Published on: October 19, 2021

    Related Experiment Videos

    Last Updated: May 10, 2026

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
    08:04

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

    Published on: June 6, 2025

    Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy
    04:41

    Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy

    Published on: October 13, 2023

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
    08:26

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

    Published on: October 19, 2021

    Area of Science:

    • Neurology
    • Genetics
    • Bioinformatics

    Background:

    • Epilepsy affects 50 million globally, with genetic factors influencing risk and treatment response.
    • Identifying genes for common epilepsy forms and epileptic encephalopathies remains a challenge.
    • The Epilepsy Phenome/Genome Project (EPGP) aims to address this gap through large-scale phenotyping and genotyping.

    Purpose of the Study:

    • To conduct a multi-institutional, retrospective phenotype-genotype study of epilepsy.
    • To gather detailed phenotypic information and DNA samples from participants with specific epilepsy forms.
    • To investigate genetic factors contributing to common epilepsy and epileptic encephalopathies.

    Main Methods:

    • The EPGP involves four phases: initiation, pilot, expansion/establishment, and close-out.
    • Key challenges addressed include study management, participant recruitment, phenotyping, and data validation.
    • The project utilizes a collaborative model with structured methods and expert data review.

    Main Results:

    • The EPGP has enrolled 4223 participants to date.
    • The study has navigated challenges in study initiation, management, recruitment, phenotyping, and data validation.
    • Solutions involved organizing a network into specialized cores with strong administrative oversight.

    Conclusions:

    • Large-scale genetic studies benefit from a well-organized network structure with defined roles.
    • Effective informatics systems, structured recruitment, and expert data review are crucial for success.
    • The EPGP demonstrates a valuable model for complex, multi-institutional genetic research in epilepsy.